Business Context and Reporting Period
This Form 8-K was filed by Akerna Corp., not American Bitcoin Corp. The report covers events occurring from September 20 through September 26, 2022, although the filing metadata identifies September 20, 2022 as the period date. Akerna’s common stock and warrants traded on Nasdaq under KERN and KERNW, respectively.
Financial and Capital Markets Metrics
- The terminated 2021 at-the-market equity program authorized up to $25.0 million of aggregate sales proceeds.
- Under the program, Akerna sold 2,372,572 common shares for aggregate gross proceeds of $2,669,473.
- The filing does not provide revenue, profit, cash flow, margins, debt, cash balance, or liquidity figures.
Material Changes and Corporate Actions
- Akerna, Oppenheimer & Co. and A.G.P./Alliance Global Partners mutually terminated the July 23, 2021 Equity Distribution Agreement. No additional shares may be sold under the 2021 ATM program.
- On September 26, 2022, the board amended the bylaws to reduce the stockholder-meeting quorum requirement from a majority of voting stock to one-third of voting stock.
- The September 20 special meeting was cancelled because 38,512,127 shares, including 3,369 special-voting-share equivalent votes, were represented, which was insufficient to establish a quorum.
- Before cancellation, 33,305,452 votes favored and 5,117,008 opposed a proposed reverse stock split.
Outlook, Risks, and Unusual Items
Akerna anticipated calling a new special meeting to consider a reverse stock split after the closing of a preferred-stock issuance referenced elsewhere in the filing. The quoted filing text does not provide the terms or closing status of that preferred-stock issuance. The principal disclosed governance risk was the inability to obtain a quorum, which delayed consideration of the reverse stock split.
Investor Verification Items
- Confirm the registrant’s identity: the filing names Akerna Corp., while the request metadata names American Bitcoin Corp.
- Verify the effective dates of the ATM termination and bylaw amendment, which are stated as September 23 and September 26, respectively.
- Review the separate filing referenced for the preferred-stock issuance and any subsequent notice of the new special meeting.
- Assess the potential dilution and capital effects of the 2,372,572 shares already sold and any proposed reverse stock split.
- Confirm current cash, debt, liquidity, and operating results in Akerna’s periodic financial statements, which are not included in this Form 8-K.